Hawaiian Kava 520 mg

product on market Capsule Maui Medicinal 🟡 Safety: 60/100
Brand: Maui Medicinal
🟡 60/100

Review before taking

  • dried Kava root powder: 520mg is 2.1× the Tolerable Upper Intake Level (250mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ dried Kava root powder: 520mg is 2.1× the Tolerable Upper Intake Level (250mg)

This product received a low safety score because its 520mg dose of Kava root powder is more than double the recommended maximum daily limit of 250mg.

Label Data

1 Capsule(s) Serving Size
60 Servings
Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

520 mg
⚠️ Exceeds Tolerable Upper Intake Level by 2.1× (UL: 250 mg) 📚 12 studies (Tier A: 0, B: 5)
This product: 520mg UL 250mg

Other Ingredients

Vegetable Capsules

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (74% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: As herbal nutrient support take 1 capsule once daily, or as directed.

⚠️ Warnings & Precautions

Keep out of reach of children

🧪 Formulation Notes

520 mg per cap

Gluten free GMO free

Vegan

Additional Information

800.936.6532

Product Details

UPC / SKU 6 73125 11145 8
DSLD Entry Date 2020-10-23
Product Type Botanical
Form Capsule
Brand Maui Medicinal
DSLD ID 235704
Data Updated 2026-04-11

Research Evidence

19 Research Sources
48 Avg Quality Score
8 Rct
5 Systematic Review
4 Meta Analysis
2 Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003
PubMed Cochrane
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018
PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001
PubMed Cochrane
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002
PubMed Cochrane
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018
PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020
PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009
PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients
PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002
PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000
PubMed
View all evidence for Kava →

Compare Similar Products

Kava
Kava Wakaya Perfection 100
Kava Kava 250 mg Natural Factors Stress-Relax 100
Kava Kava 200 mg Natrol 100
Kava Extract 250 mg Vital Nutrients 100
Restal Indiana Botanic Gardens 100
View all Kava products →
Kava research & evidence Best Kava rankings All Kava products More from Maui Medicinal View on NIH DSLD →